Clinical Drug Development Consulting AG
Latest commercial register entry
Map & Directions
Review
Commercial register ID for Clinical Drug Development Consulting AG:
CH-241.3.011.619-3
Unique enterprise identification number (UID) for Clinical Drug Development Consulting AG:
CHE-164.914.179
About Clinical Drug Development Consulting AG
Clinical Drug Development Consulting AG, based in Flüh, is a company in Switzerland. Clinical Drug Development Consulting AG is active according to the commercial register. Clinical Drug Development Consulting AG was registered in the Swiss Commercial Register on February 22, 2013. Itsunique enterprise identification number (UID) is CHE-164.914.179.
A total of 2 official publications concerning Clinical Drug Development Consulting AG have been recorded on HELP.CH in the Swiss Official Gazette of Commerce (SOGC) database, which contains publications from January 2007 onwards. You can see the latest publication by company Clinical Drug Development Consulting AG from August 12, 2022 on this link.
Registered Business Purpose of Clinical Drug Development Consulting AG
Providing drug development services to the pharmaceutical industry in Germany and abroad. Can set up branch offices in Switzerland and abroad, participate in other domestic and foreign companies, acquire or merge with similar or related companies, enter into all business and enter into contracts suitable for promoting the purpose of the company or directly or indirectly related thereto, further acquiring, managing, encumbering and disposing of real estate, copyright, patents and licenses of any kind.
Automatically translated from German.Clinical Drug Development Consulting AG in Flüh is listed on Yellowpages.swiss. Latitude and longitude coordinates for Clinical Drug Development Consulting AG are: 47.4827185 and 7.4934637. The Swiss enterprise identification number (UID) of Clinical Drug Development Consulting AG is CHE-164.914.179.
Primary Data Source: Swiss Commercial Register (SOGC / FSO)
Other companies registered at the same address as Clinical Drug Development Consulting AG (St. Annaweg, 4112 Flüh include: Fidacon Jürg Wernli | Sykrito GmbH .
Press Releases from Clinical Drug Development Consulting AG
Frequently Asked Questions about Clinical Drug Development Consulting AG in Flüh
We have compiled the most important questions and answers about Clinical Drug Development Consulting AG in Flüh.
What is the registered address of Clinical Drug Development Consulting AG?
The registered business address of Clinical Drug Development Consulting AG is St. Annaweg 28, 4112 Flüh.
When was Clinical Drug Development Consulting AG registered?
The Swiss Commercial Register entry for Clinical Drug Development Consulting AG is dated February 22, 2013. The company may have been established before this date.
About Flüh
Clinical Drug Development Consulting AG is registered in the municipality of Flüh. Flüh is a municipality in the canton of Solothurn. Solothurn is a canton in German-speaking Switzerland and is part of the greater Espace Mittelland region. The capital is the eponymous city of Solothurn, the most populous place is Olten. The canton of Solothurn is one of 26 cantons in the Swiss Confederation.
Flüh is a municipality in the canton of Solothurn, in the country of Switzerland, on the continent of Europe. Latitude and longitude coordinates for Flüh are: 47.485313 and 7.4986351. The local date and time in Flüh is October 23, 2026, 6:34 AM.
The information on this entry in the commercial register of the legal entity Clinical Drug Development Consulting AG is provided without guarantee and has no legal effect. Only the certified extracts from the commercial register and the publication texts in the Swiss Official Gazette of Commerce (SOGC) are binding.
Search Directory
Romande Energie accelerates progress towards its target of 5 TWh of low-carbon power generation Romande Energie SA, 2026-10-22
Third-quarter and nine-month 2026 sales - Nestlé Suisse Nestlé Suisse S.A., 2026-10-22
Galderma delivers net sales of 4.765 B USD in the first nine months, up 25.1% at constant currency year-on-year, and rai Galderma SA, 2026-10-22
